Thanks Doug. And good morning, everyone. We had a great quarter as the strategic growth initiatives we've been executing over the past several quarters, combined with strong consumer demand to drive healthy receivables growth. Delinquency levels remain below the comparable period of 2019 and net charge-offs reached an historic low of 3.5%. We remain confident in our full year guidance for net charge-offs of approximately 4.2% and manage receivables growth in 8% to 10% range. We are $288 million of net income or $2.17 per diluted share in the quarter, up 17% on a per share basis from the third quarter of 2020. On an adjusted C&I basis, we earned $316 million, or $2.37 per diluted share, up 8% on a per share basis from the third quarter of 2020. Capital generation or C&I adjusted earnings, excluding the impact of changes in loan loss reserves, was $360 million in the third quarter, up $66 million or 22% over prior year. Manage receivables grew to $19.1 billion, up over $800 million from the second quarter and up $1.3 billion or 7% from a year ago, reflecting strong consumer demand and the continued impact of our growth initiatives. Interest income was $1.1 billion in the third quarter, up 2% compared to the prior year, primarily driven by higher average net receivables. Portfolio yield was 23.8% as compared to 24.3% in the third quarter of last year, and 24.1% in third quarter of 2019. The modest decline was a result of competitive risk based pricing with better credit quality customers, which has contributed meaningfully to our receivables growth, while exceeding our minimum 20% return on tangible common equity threshold. For the full year, we continue to expect yield to be approximately 24%. Interest expense was $235 million, down $15 million or 6% versus the prior year, as we continue to benefit from the ongoing liability management actions we are taking to reduce our cost of funds. Interest expense as a percentage of average receivables improved year-over-year from 5.6% a year ago to 5.0% this quarter. We continue to expect full year interest expense to be in the range of 5.0% to 5.2%. Other revenue was $152 million in the third quarter, up 13% compared to the prior year quarter. The increase was driven by economics from our whole loan sale program, primarily $15 million of gain on sale revenue from the $160 million of loans sold during the quarter. In August, we added a third partner to our whole loan sale program, which increased our ongoing sales to $180 million per quarter. Our intent has been to scale these partnerships to a meaningful level, which we have done. On an annual basis, our current level of loan sales will add $720 million of committed funding to our already strong capital markets programs. Policyholder benefits and claims expense was $45 million in the third quarter, up 3% compared to the prior year. As discussed previously, over the last few quarters our IUI claims have consistently moderated since the second quarter 2020 pandemic driven peak and are now back to normal levels. Let's turn to Slide 9 to review our originations and receivables trends. We originated $3.9 billion in the third quarter, up 34% from third quarter of 2020 and 6% higher than the third quarter of 2019. You may recall that last quarter originations improved progressively each month of the quarter. Originations remained strong throughout this quarter, resulting in manage receivables growth of 7% year-over-year and 6% since the end of last year. Our managed receivables this quarter include about $283 million of receivable sold that serviced by OneMain for our whole loan sale partners. Let's now turn to Slide 10, and walk through our recent credit trends. Strong credit performance continued into the third quarter as net charge-offs reached an all time low of 3.5%. This strong performance reflects the impact of government stimulus and the resulting low for 30 to 89 delinquencies in the first quarter of this year. Strong late stage delinquency performance also contributed positively to our charge-offs. As an example, third quarter recoveries were $58 million, $22 million or 61% better than the pre-pandemic comparison period of third quarter 2019. We expect net charge-offs to show a modest seasonal increase in Q4 yet remains still well below 2019 levels. And we remain confident in our full year 2021 net charge-off guidance of approximately 4.2%. 30 to 89 delinquency in the quarter was 2.20%, 10 basis points below the third quarter of 2019. 90 plus delinquency was 1.57%, 36 basis points below the third quarter of 2019. As we've discussed previously, delinquency will trend towards normal levels, as the positive impacts of government stimulus are further behind us. Our loan loss reserve trends are shown on Slide 11, after reducing our loan loss reserves by combined $331 million over the past three quarters, our reserves increased $59 million this quarter to about $2.1 billion while our reserve ratio declined to 11.0%. Our reserve increase was driven entirely by portfolio growth and our loan loss reserve ratio reflects improving economic forecasts yet some level of uncertainty that continues in the environment. As of the end of the third quarter, we have released nearly all of the reserves we had built associated with the pandemic in 2020. We have strong confidence in the future credit performance of our portfolio, as indicated by our loan loss reserve ratio, which is now just 3% above pre-pandemic levels. Turning to Slide 12, third quarter operating expense was $338 million. Our third quarter operating expense grew 1% against comparable third quarter 2019 levels, even as we continue to accelerate investment and growth initiatives. And while our receivables grew by more than 7% over that period, our current period OpEx ratio of 7.2% is well below the 7.6% ratio achieved in third quarter 2019, benefiting from the efficiencies we've driven over the past several years, and illustrating the strong operating leverage of our business. We expect full year 2021 operating expense to be at the higher end of our 5% to 7% growth range, given our continued investment in the business and continued strong loan growth. Let's now move on to the balance sheet on Slide 13. Our significant liquidity sources include about $600 million of available cash, $7.3 billion in undrawn conduit capacity, and $11 billion of unencumbered receivables. Once again, we've been busy on the funding side of our business. In August, we raised $600 million of seven year unsecured notes at 3.875%. And earlier this month, we issued a $1 billion ABS deal at a weighted average coupon of just 0.98% reflecting strong demand for our paper and once again demonstrating the strength and maturity of our funding capabilities. Across our last three ABS deals, we have raised nearly $3 billion and an average coupon of approximately 1.5% and an average term of approximately five years. Our balance sheet has never been stronger. And we believe our funding cost improvements will give us even more leverage to grow our balance sheet in future years. I'm also very pleased the strength and momentum in our business was recognized by Moody's who recently upgraded our long-term corporate rating to BA2. We continue to focus on delivering on our capital allocation framework, which includes delivering portfolio growth and attractive returns, investing in our business and our future and returning considerable capital to our shareholders. At September 30, our leverage was 5.4x, leverage was up modestly from last quarter, reflecting capital return actions in the quarter, we paid our regular $0.70 per share quarterly dividend, plus an enhanced dividend of $3.50 per share. We also repurchase more than 2.4 million shares for $141 million. On Slide 16, we've laid out our consistently strong dividend history, including the $0.70 per share regular dividend to be paid in November, we will pay out $9.55 per share during the last 12 months, equating to a dividend yield of approximately 16% at the recent share price. With that, I'll turn the call back over to Doug.